Credit Suisse Ag Bausch Health Companies Inc. Put Options Transaction History

Credit Suisse Ag

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $16.3 Million - $19.6 Million	-651,400 Reduced 98.7%	8,600 $240,000
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $16.5 Million - $19.6 Million	-600,800 Reduced 47.65%	660,000 $19.3 Million
Q1 2021 May 14, 2021	SELL	$21.37 - $34.38 $8.16 Million - $13.1 Million	-381,800 Reduced 23.24%	1,260,800 $40 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $20.3 Million - $28 Million	1,327,100 Added 420.63%	1,642,600 $34.2 Million
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $3.06 Million - $4.14 Million	205,500 Added 186.82%	315,500 $4.9 Million
Q3 2019 Nov 12, 2019	BUY	$20.88 - $25.66 $611,784 - $751,838	29,300 Added 36.31%	110,000 $2.4 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $1.01 Million - $1.3 Million	49,100 Added 155.38%	80,700 $2.04 Million
Q1 2019 May 14, 2019	SELL	$20.23 - $26.29 $30 Million - $39 Million	-1,482,700 Reduced 97.91%	31,600 $781,000
Q4 2018 Feb 13, 2019	BUY	$17.64 - $28.32 $6.17 Million - $9.91 Million	350,000 Added 30.06%	1,514,300 $28 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $24 Million - $29.9 Million	1,164,300 New	1,164,300 $29.9 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.66B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.